Myrexis (MYRX) Director Buys 70,218 Shares
Tweet
Share
E-mail
In an SEC filing on Myrexis (Nasdaq: MYRX) after the close Monday, a director, Jason Aryeh, disclosed the purchase of 70,218 shares of common stock on Dec. 1st and 2nd at a price of $2.65-$2.69.
The director now holds 440,144 shares of Myrexis.
The director now holds 440,144 shares of Myrexis.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Gossamer Bio raises up to $250M in private placement for PAH drug
- Milestone Pharmaceuticals starts Phase 3 AFib-RVR trial for etripamil
Create E-mail Alert Related Categories
Insider TradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
